A Phase 2, Prospective Study Of PRM-151 In Subjects With Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV MF), Or Post-Essential Thrombocythemia MF (Post-ET MF)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT01981850

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:38:21.531581+00:00

Published At

2022-01-05T00:00:00+00:00

Record Updated At

2022-01-05

Results Posted At

2022-01-05

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Primary Myelofibrosis", "Polycythemia Vera", "Post-Essential Thrombocythemia Myelofibrosis"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2022-01-05"

protocolSection.identificationModule.nctId

"NCT01981850"

protocolSection.identificationModule.officialTitle

"A Phase 2, Prospective Study Of PRM-151 In Subjects With Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV MF), Or Post-Essential Thrombocythemia MF (Post-ET MF)"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

["PHASE2"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

"2022-01-05"

Study condition terms

• Primary Myelofibrosis (protocolSection.conditionsModule.conditions)
• Polycythemia Vera (protocolSection.conditionsModule.conditions)
• Post-Essential Thrombocythemia Myelofibrosis (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.